Markku J. Maki

Pl 100
Tampere, 33014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 124 publications

Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease.

Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease.

Journal: BMC medicine

Published: January 13, 2026

Bulb biopsies for diagnosing celiac disease in children: A prospective multicenter study using quantitative histomorphometry.

Bulb biopsies for diagnosing celiac disease in children: A prospective multicenter study using quantitative histomorphometry.

Journal: Journal of pediatric gastroenterology and nutrition

Published: May 28, 2025

Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies.

Development of Cell-Assembled Human Endomysial-Type Biomatrix Substrate for the Detection of Celiac Disease Autoantibodies.

Journal: International journal of molecular sciences

Published: December 31, 2024

Trends in the prevalence rates and predictive factors of coeliac disease: A long-term nationwide follow-up study.

Trends in the prevalence rates and predictive factors of coeliac disease: A long-term nationwide follow-up study.

Journal: Alimentary pharmacology & therapeutics

Published: July 10, 2023

Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.

Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.

Journal: Nature immunology

Published: June 22, 2023

A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and Inflammation.

A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and Inflammation.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 31, 2023

The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.

The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.

Journal: International journal of molecular sciences

Published: May 16, 2023

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.

Journal: The lancet. Gastroenterology & hepatology

Published: April 27, 2022

Healthy and pro-inflammatory gut ecology plays a crucial role in the digestion and tolerance of a novel Gluten Friendly™ bread in celiac subjects: a randomized, double blind, placebo control in vivo study.

Healthy and pro-inflammatory gut ecology plays a crucial role in the digestion and tolerance of a novel Gluten Friendly™ bread in celiac subjects: a randomized, double blind, placebo control in vivo study.

Journal: Food & function

Published: January 14, 2022

A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply.

A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply.

Journal: The New England journal of medicine

Published: October 13, 2021

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.

Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.

Journal: Gastroenterology

Published: September 20, 2021

Dissecting the contribution of single nucleotide polymorphisms in CCR9 and CCL25 genomic regions to the celiac disease phenotype.

Dissecting the contribution of single nucleotide polymorphisms in CCR9 and CCL25 genomic regions to the celiac disease phenotype.

Journal: Journal of translational autoimmunity

Published: August 12, 2021

Showing 1-12 of 124

Last Updated: 09/26/2026